Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Tipo del documento
País de afiliación
Colección Odontología Uruguay
Intervalo de año de publicación
1.
Osteoporos Int ; 20(11): 1863-72, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19280272

RESUMEN

UNLABELLED: Prior 8-week treatment with menatetrenone, MK-4, followed by 8-week risedronate prevented the shortcomings of individual drugs and significantly increased the strength of ovariectomized ICR mouse femur compared to the ovariectomized (OVX) controls. Neither MK-4 following risedronate nor the concomitant administration may be recommended because they brought the least beneficial effect. INTRODUCTION: The objective of this study was to determine the best combinatory administration of risedronate at 0.25 mg/kg/day (R) with vitamin K(2) at approximately 100 microg MK-4/kg/day (K) to improve strength of osteoporotic mouse bone. METHODS: Thirteen-week-old ICR mice, ovariectomized at 9-week, were treated for 8 weeks with R, K, or R plus K (R/K), and then, either the treatment was withdrawn (WO) or switched to K or R in the case of R and K. After another 8 weeks, the mice were killed, and mechanical tests and analyses of femur properties by peripheral quantitative computed tomography, microfocus X-ray tube computed tomography, and confocal laser Raman microspectroscopy were carried out. RESULTS: The K to R femur turned out superior in parameters tested such as material properties, bone mineral density, BMC, trabecular structure, and geometry of the cortex. The increased cross-sectional moment of inertia, which occurred after K withdrawal, was prevented by risedronate in K to R. In addition to K to R, some properties of R to WO diaphysis and K to WO epiphysis were significantly better than OVX controls. CONCLUSION: Prior treatment with MK-4 followed by risedronate significantly increased femur strength in comparison to the OVX controls.


Asunto(s)
Conservadores de la Densidad Ósea/uso terapéutico , Ácido Etidrónico/análogos & derivados , Osteoporosis/tratamiento farmacológico , Vitamina K 2/análogos & derivados , Animales , Peso Corporal/efectos de los fármacos , Conservadores de la Densidad Ósea/administración & dosificación , Esquema de Medicación , Evaluación Preclínica de Medicamentos/métodos , Quimioterapia Combinada , Ácido Etidrónico/administración & dosificación , Ácido Etidrónico/uso terapéutico , Femenino , Fémur/patología , Fémur/fisiopatología , Ratones , Ratones Endogámicos ICR , Osteoporosis/fisiopatología , Ovariectomía , Ácido Risedrónico , Vitamina K 2/administración & dosificación , Vitamina K 2/uso terapéutico
2.
Dentomaxillofac Radiol ; 39(4): 207-15, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20395461

RESUMEN

OBJECTIVES: The aim of the study was to clarify the change in image quality upon X-ray dose reduction and to re-analyse the possibility of X-ray dose reduction in photostimulable phosphor luminescence (PSPL) X-ray imaging systems. In addition, the study attempted to verify the usefulness of multiobjective frequency processing (MFP) and flexible noise control (FNC) for X-ray dose reduction. METHODS: Three PSPL X-ray imaging systems were used in this study. Modulation transfer function (MTF), noise equivalent number of quanta (NEQ) and detective quantum efficiency (DQE) were evaluated to compare the basic physical performance of each system. Subjective visual evaluation of diagnostic ability for normal anatomical structures was performed. The NEQ, DQE and diagnostic ability were evaluated at base X-ray dose, and 1/3, 1/10 and 1/20 of the base X-ray dose. RESULTS: The MTF of the systems did not differ significantly. The NEQ and DQE did not necessarily depend on the pixel size of the system. The images from all three systems had a higher diagnostic utility compared with conventional film images at the base and 1/3 X-ray doses. The subjective image quality was better at the base X-ray dose than at 1/3 of the base dose in all systems. The MFP and FNC-processed images had a higher diagnostic utility than the images without MFP and FNC. CONCLUSIONS: The use of PSPL imaging systems may allow a reduction in the X-ray dose to one-third of that required for conventional film. It is suggested that MFP and FNC are useful for radiation dose reduction.


Asunto(s)
Dosis de Radiación , Intensificación de Imagen Radiográfica/métodos , Tomografía Computarizada por Rayos X/métodos , Adulto , Proceso Alveolar/diagnóstico por imagen , Artefactos , Esmalte Dental/diagnóstico por imagen , Cavidad Pulpar/diagnóstico por imagen , Dentina/diagnóstico por imagen , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Mandíbula/diagnóstico por imagen , Ligamento Periodontal/diagnóstico por imagen , Fantasmas de Imagen , Radiografía de Mordida Lateral , Tomógrafos Computarizados por Rayos X , Raíz del Diente/diagnóstico por imagen , Película para Rayos X , Pantallas Intensificadoras de Rayos X
3.
Dentomaxillofac Radiol ; 38(1): 34-41, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19114422

RESUMEN

OBJECTIVES: The aim of this study was to clarify the effects of steroid treatment on the mandible. METHODS: We divided 24 male Fisher rats, aged 10 weeks, into 2 groups: a control group (n = 11) and a prednisolone (Pred) treatment group (n = 13). The dose for the Pred group was 40 mg kg(-1) and was administered orally three times per week for 8 weeks. At the end of the experiment, we measured bone mass, bone strength and trabecular structure of the mandible and femur. RESULTS: Pred treatment decreased cortical bone mineral content (BMC), cortical thickness, stress/strain index and tissue volume of the mandible. However, there were no marked changes in trabecular structure parameters. A strong correlation was seen between mandibular and femoral cortical BMC (r = 0.71). CONCLUSIONS: These findings suggest that steroid treatment decreases the cortical BMC, bone area and bone strength of the mandible.


Asunto(s)
Densidad Ósea/efectos de los fármacos , Glucocorticoides/farmacología , Mandíbula/efectos de los fármacos , Osteoporosis/inducido químicamente , Prednisolona/farmacología , Animales , Fenómenos Biomecánicos , Fémur/efectos de los fármacos , Masculino , Ratas , Ratas Endogámicas F344 , Microtomografía por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA